Gabelli Funds LLC Organogenesis Holdings Inc. Transaction History

Gabelli Funds LLC

  • $12.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022
BUY
$3.14 - $6.43 $13,235 - $27,102
4,215 Added 16.62%
29,575 $96,000
Q1 2022

May 13, 2022
BUY
$6.47 - $9.57 $97,050 - $143,550
15,000 Added 144.79%
25,360 $193,000
Q4 2021

Feb 11, 2022
BUY
$9.02 - $13.5 $93,447 - $139,860
10,360 New
10,360 $96,000

Others Institutions Holding ORGO

# of Institutions
118
Shares Held
64.3M
Call Options Held
25K
Put Options Held
23.2K
View Full List

About Organogenesis Holdings Inc.

ORGO Quotes by TradingView
  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $462M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email